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Abstract
Tuberculosis requires rapid diagnosis to prevent further transmission and allow prompt administration of treatment. Current
methods for diagnosing pulmonary tuberculosis lack sensitivity are expensive or are extremely slow. The identification of
lipids using gas chromatography- electron impact mass spectrometry (GC-EI/MS) could provide an alternative solution. We
have studied mycocerosic acid components of the phthiocerol dimycocerosate (PDIM) family of lipids using
thermochemolysis GC-EI/MS. To facilitate use of the technology in a routine diagnostic laboratory a simple extraction
procedure was employed where PDIMs were extracted from sputum using petroleum ether, a solvent of low polarity. We
also investigated a method using methanolic tetramethylammonium hydroxide, which facilitates direct transesterification of
acidic components to methyl esters in the inlet of the GC-MS system. This eliminates conventional chemical manipulations
allowing rapid and convenient analysis of samples. When applied to an initial set of 40 sputum samples, interpretable
results were obtained for 35 samples with a sensitivity relative to culture of 94% (95%CI: 69.2,100) and a specificity of 100%
(95%CI: 78.1,100). However, blinded testing of a larger set of 395 sputum samples found the assay to have a sensitivity of
61.3% (95%CI: 54.9,67.3) and a specificity of 70.6% (95%CI: 62.3,77.8) when compared to culture. Using the results obtained
we developed an improved set of classification criteria, which when applied in a blinded re-analysis increased the sensitivity
and specificity of the assay to 64.9% (95%CI: 58.6,70.8) and 76.2% (95%CI: 68.2,82.8) respectively. Highly variable levels of
background signal were observed from individual sputum samples that inhibited interpretation of the data. The diagnostic
potential of using thermochemolytic GC-EI/MS of PDIM biomarkers for diagnosis of tuberculosis in sputum has been
established; however, further refinements in sample processing are required to enhance the sensitivity and robustness of
the test.
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Introduction
Tuberculosis (TB) is a global health problem. The World
Health Organization estimated 9.4 million incident cases during
2009 and 1.7 million deaths [1]. The challenge in reducing the
global burden of tuberculosis is rapid diagnosis followed by
appropriate treatment. Current methods of diagnosing TB are
inadequate. The most widely used test, microscopic examination
of sputum, lacks sensitivity and global cases detection rates remain
low [2]. It is estimated that only 63% of incident cases are detected
each year [1]. Definitive diagnosis requires isolation and culture of
the bacilli which may take weeks and requires considerable
laboratory infrastructure to protect against infection [2,3].
Detection of lipid moieties, which are essential components of
the cell envelope of Mycobacterium tuberculosis, offers an alternative
approach for diagnosis. Chemical analysis has the advantage over
culture methods in that it can be rapid and does not require live
organisms. The mycocerosic acid components of the phthiocerol
dimycocerosate (PDIM) family of complex lipids are established
diagnostic markers for tuberculosis [4,5]. Fatty acids of this type
are found in M. tuberculosis, Mycobacterium bovis, Mycobacterium
kansasii, Mycobacterium leprae, Mycobacterium marinum, Mycobacterium
gastri, Mycobacterium haemophilum and Mycobacterium ulcerans [6,7,8].
Members of the M. tuberculosis complex have a characteristic profile
composed of trimethyl C29 and tetramethyl C30 and C32
mycocerosates (Figure 1), while the other related mycobacteria
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has previously been performed using gas chromatography (GC)
followed by electron capture detection or negative ion chemical
ionisation MS [4,5,9,10], including detection in sputum [5,10].
M. tuberculosis PDIMs are highly stable waxes, composed of
mixtures of long-chain multimethyl-branched mycocerosic acids
esterified to C34 and C36 long-chain diols, the phthiocerols ([4,8]).
Degradation of these extremely hydrophobic waxes requires
strong chemical methods. Alkaline hydrolysis requires an over-
night non-aqueous potassium hydroxide/methanol/toluene treat-
ment system [4,9]. Alternatively, the PDIMs may be cleaved by
reduction [7,11], but such a procedure is complex and lengthy and
unattractive for rapid detection or use in a clinical diagnostic
laboratory.
An advantage of the PDIM lipids over other lipid entities is their
exceptionally low polarity, which enables them to be preferentially
extracted by non-polar solvents [10,12], separating them from the
majority of the other mycobacterial and mammalian lipids. We
have investigated a simple extraction procedure followed by
thermally assisted hydrolysis and methylation (THM), prior to the
analysis by gas chromatography (GC) coupled with electron
impact mass spectrometry (EI/MS), to ascertain the potential for a
rapid diagnostic test for pulmonary tuberculosis based on detection
of the mycocerosic acid components of PDIMs. This protocol
involves heating samples with methanolic tetramethylammonium
hydroxide (TMAH), which facilitates direct transesterification of
the acidic components to methyl esters [13]. Performing this
transformation in the programmable temperature vaporization
(PTV) inlet of a GC-MS eliminates conventional chemical
manipulations allowing rapid analysis of clinical samples. The
novelty of this work is the application of THM-GC-EI/MS to the
analysis of PDIMs extracted from sputum.
Results
Thermochemolytic-gas chromatography-electron impact mass
spectrometry (THM-GC-EI/MS) of standard phthiocerol dimy-
cocerosate (PDIM) waxes generated profiles characteristic of
mycocerosic acid methyl esters from M. tuberculosis. The diagnostic
mycocerosates are trimethyl C29 and tetramethyl C30 and C32
acids [4,9]. As shown in Figure 2, each mycocerosate is
represented as a characteristic double peak due to racemisation
during the alkaline hydrolysis [4]. As explained in the discussion
section, the earlier eluting double peak represents overlapping
trimethyl C29 and tetramethyl C30 mycocerosates; the additional
methyl branch in the larger C30 mycocerosate increases its
volatility so that it co-elutes with the smaller C29 component. The
Figure 1. Structures of the M. tuberculosis C29,C 30 and C32
mycocerosic acid methyl esters. The ions at m/z 452, 466 and 494
correspond to the molecular weights of these esters. Ions at m/z 88 and
101 are characteristic for 2-methyl branched fatty acid methyl esters,
the former resulting from a well-known ‘‘McLafferty’’ rearrangement
with transfer of one hydrogen atom.
doi:10.1371/journal.pone.0032836.g001
Figure 2. Thermochemolytic-gas chromatography-electron impact/mass spectrometry (THM-GC-EI/MS) of purified phthiocerol
dimycocerosate (PDIM) waxes. The selected ion monitored EI/MS chromatogram shows the target fragment ions m/z 101 and m/z 88, resulting
from the major trimethyl C29 and tetramethyl C30, and C32 mycocerosates released by thermochemolysis of the PDIMs. A minor proportion of a
tetramethyl C31 mycocerosate is also indicated. The characteristic doublet peaks are due to racemisation during the alkaline hydrolysis. The method
relied on recognizing comparable proportions of the combined C29/C30 peak and the C32 peak, as was the case in all the positive specimens. Some
minor variation in the ratios of the individual peaks was observed, but this did not affect the diagnostic ratios.
doi:10.1371/journal.pone.0032836.g002
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of tetramethyl C32 mycocerosate.
Spiking of negative sputum with PDIMs standard
Sputum samples were processed using sodium hydroxide in a
standard decontamination procedure routinely applied prior to M.
tuberculosis culture [14]. Apolar lipids were extracted from samples
with petroleum ether 60–80uC (PE) using a modified method from
Dobson et al.. Duplicate analyses of extracts obtained from
negative sputum samples spiked with PDIMs standard (140–
27,500 pg/mL) demonstrated that the yield of the mycocerosic
acid methyl esters was proportional to the amount of material
added, within the range tested (Figure 3). Both the C29/C30 and
C32 peaks were clearly visible in the extract spiked at the lowest
level analyzed, 140 pg of PDIMs (equivalent to 7 pg of PDIMs
loaded in liner), with an average signal to noise ratio (S/N) of 9.1
for C29/C30, and of 39.3 for C32.
Spiking of negative sputum with culture
Duplicate analyses of the extracts obtained from pooled
negative sputum samples spiked with M. tuberculosis culture (140–
5,600 CFU per mL) indicated that the areas of the mycocerosic
acid methyl esters peaks showed a linear relationship with the
number of bacteria in the range tested (Figure 4). As can be seen in
Figure 5, both the C29/C30 and C32 peaks were clearly visible in
the extract spiked at the lowest level analyzed 140 CFU per mL,
and had an average signal to noise ratio (S/N) of 36.2 for C29/C30,
and 55.3 for C32.
Identification of mycocerosic acids in clinical isolates
Sputum samples from suspected TB cases were processed in two
batches; the first panel (the test batch) consisted of 40 samples (20
smear positive culture positive and 20 smear and culture negative),
and the second panel (the evaluation batch) consisted of 395
samples. All samples were subjected to smear microscopy and
Figure 3. THM-GC-EI/MS of sputum spiked with PDIMs. The graphs show the peak areas obtained for C29/C30 and C32 mycocerosates
generated from spiking 0.2 mL of pooled TB negative sputum samples with PDIM standard, (A) in the range 0.14–2.75 ng, and (B) expanding the
range between 0.14–27.5 ng.
doi:10.1371/journal.pone.0032836.g003
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On blinded testing the panel of 40 sputum samples, mycocerosic
acids were identified in 14/20 smear and culture positive sputum
specimens. Three smear and culture positive sputum specimens
were incorrectly assigned as negative and the remaining three were
assigned as indeterminate. Of the smear and culture negative
sputum specimens, 18/20 were assigned as negative and the
remaining 2/20 were classified as indeterminate. Following un-
blinding, the characteristic doublet peaks were identified at the
appropriate retention times, in two of the false negatives. They
were initially miss-classified owing to their low abundance within a
high matrix background. When the 5 undetermined samples were
excluded from the analysis, the unblinded results obtained
demonstrated a sensitivity of 94% (95%CI: 69.2,100) and a
specificity of 100% (95%CI: 78.1,100). Figure 6 shows example
chromatograms for (a) a negative sputum sample, and two positive
sputum samples with a (b) high and (c) low level of PDIMs. A
further 395 sputum samples were then analyzed in a blinded
fashion by THM-GC-EI/MS, based on initial classification
criteria, namely the presence of doublets in the m/z 101 and m/
z 88 chromatograms at the expected retention times. Results are
presented in Table 1. Four samples were not determined by
THM-GC-EI/MS and were excluded from further analysis as
their chromatograms were uninterpretable due to overloading of
the column. Of the remaining 391 samples THM-GC-EI/MS
detected 68.8% (95%CI: 61.9,75) of smear positive culture
confirmed cases and 25.6% (95%CI: 13.9,41.5) of smear negative
cases. Sensitivity for detection of culture confirmed TB cases was
61.3% (95%CI: 54.9,67.3) and the specificity was 70.6% (95%CI:
62.3,77.8).
Following unblinding, chromatograms were re-studied to
evaluate where errors had been made and whether lessons could
be learnt about their misclassification. False negatives were
identified where small characteristic doublet peaks had been
Figure 4. THM-GC-EI/MS of sputum spiked with M. tuberculosis bacilli. The graph shows the peak areas obtained for C29/C30 and C32
mycocerosates generated from spiking 1 mL of pooled TB negative sputum sample with M. tuberculosis culture (140–5,600 CFU/mL).
doi:10.1371/journal.pone.0032836.g004
Figure 5. THM-GC-EI/MS traces of TB negative sputum spiked with M. tuberculosis bacilli. The chromatograms show the fragment ions m/z
101 and m/z 88 for the extract from 1 ml sample of TB negative sputum spiked with 140 CFU of M. tuberculosis culture.
doi:10.1371/journal.pone.0032836.g005
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where instead of a doublet, two closely eluting peaks had actually
been observed at, or close to, the anticipated retention times, or
where doublets appeared but not at the in correct retention times.
To provide a more careful assessment of chromatograms, revised
classification criteria where drawn up, focusing on a more
stringent approach to the chromatographic alignment, and to
strictly matching retention times and the doublets profiles with the
daily standard runs.
A positive result was assigned to a chromatogram showing the
following features:
(i) the presence of the characteristic doublets in both m/z 101
and m/z 88 traces, at the retention times for both C29/C30
and C32, respectively;
(ii) the time interval between the two characteristic doublets in
the sputum sample to rigorously match that in the PDIM
standard daily run;
(iii) the doublet peak at C29/C30 to be comparable in size to
the doublet peak at C32, in both ion chromatograms m/z
101 and m/z 88;
(iv) both the m/z 101 and m/z 88 traces closely matching each
other in shape and size.
A negative result was assigned to the following features:
(i) the absence of one or both of the characteristic doublets at
the expected retention time in the m/z 101 and m/z 88 ion
chromatograms;
(ii) the presence of a single peak at either of the expected
retention times in the m/z 101 and m/z 88 ion
chromatograms
(iii) the presence of two closely eluting, but distinct peaks,
instead of doublets, at either of the expected retention
times in the m/z 101 and m/z 88 ion chromatograms;
(iv) a time interval between the suspected C29/C30 and C32
signals not matching rigorously that in the daily standard
run;
(v) the doublets at C29/C30 and at C32 are not comparable in
size
(vi) the traces of m/z 101 and m/z 88 ion chromatograms do
not match each other in shape and size.
The chromatograms were then re-blinded and examined by a
newly trained analyst, with no prior contact with the data. Data
obtained are presented in Table 2. This approach resulted in the
detection of 74.1% (95%CI: 67.5,79.9) of smear positive culture
confirmed cases and 20.9% of smear negative cases (95%CI:
10.6,36.5). Its overall sensitivity relative to culture was 64.9%
(95%CI: 58.6,70.8) and the specificity was 76.2% (95%CI:
68.2,82.8).
Figure 6. Examples of THM-GC-EI/MS chromatograms from
sputum specimens from suspected TB cases. Chromatograms
show the profile of the fragment ion m/z 101 in (A) negative, and
positive sputum samples with (B) high, and (C) low amounts of PDIMs
present. Note the characteristic doublets for the mycocerosic acid
methyl esters C29/C30 and C32 in b–c.
doi:10.1371/journal.pone.0032836.g006
Table 1. Performance of THM-GC-EI/MS compared to smear microscopy and culture on Lowenstein-Jensen for detection M.
tuberculosis in 395 sputum samples.
Culture positive
Smear positive
Culture positive
Smear negative Culture negative Total samples
THM-GC-EI/MS positive 141 11 42 194
THM- GC-EI/MS negative 64 32 101 197
Indeterminate
# 11 2 4
Total samples 206 44 145 395
#Four samples were not determined due to overloading of the GC column and were excluded from further analysis.
doi:10.1371/journal.pone.0032836.t001
Mycocerosates from M. tuberculosis in Sputum
PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e32836Discussion
This study has demonstrated the use of mycocerosic acids as a
biomarker for diagnosis of tuberculosis disease from sputum. In
principle, the method involves preferential extraction of the apolar
PDIM waxes into PE solution and the PDIMs are then heated
with methanolic TMAH in the inlet of the GC-MS instrument.
This alkaline reagent hydrolyzes the PDIMs to yield tetrameth-
ylammonium salts of the mycocerosic acids, which pyrolyse to
produce methyl mycocerosates with the molecular formulae shown
in Figure 1 [13]. For fatty acids with methyl branches in the 2- and
4-positions the alkaline hydrolysis randomizes the natural
configuration at position 2 in a process known as ‘‘racemisation’’.
The configuration at position 4 is not disturbed, so the interaction
between the methyl branches at positions 2 and 4 can occur in two
ways, producing physically distinct compounds, termed ‘‘diaste-
reoisomers’’. These components are readily separated on the GC
column (Figure 2); for example, the first C32 mycocerosate peak is
the natural acid followed by similar proportions of the racemised
acid. Such double peaks are a diagnostic feature for 2,4-dimethyl-
branched fatty acids, such as the mycocerosates (Figure 1). The
two peaks for the C29/C30 mycocerosate are actually two
overlapping doublets for each separate mycocerosate; the
additional methyl branch in the larger C30 mycocerosate increases
its volatility so that it co-elutes with the smaller C29 component.
In the bacteria culture studied, methyl mycocerosates were
detected in PE extracts from sputum samples spiked at a level of
140 CFU mL
21, suggesting a sensitivity considerably greater than
that of smear microscopy which is estimated to require 10
4 CFU
mL
21 [15,16]. When testing the sputum samples it was necessary
to concentrate the sputum deposit and extract the samples. We
applied the standard decontamination procedures used in
diagnostic culture laboratories and heat treated samples to sterilize
and allow safe handling in the open laboratory. We then applied a
simple extraction of the apolar lipids prior to analysis by THM-
GC-EI/MS. Initial analysis of 40 sputum samples taken from TB
suspects with well defined clinical and bacteriological outcomes
provided interpretable results from 35 (87.5%) samples. Following
unblinding of the microbiological data, improved assignment was
possible and results were obtained from 92.5% of samples tested
with a further 2 samples identified as THM-GC-EI/MS positives,
suggesting that high sensitivity was achievable. When the assay
was evaluated with a larger set of sputum specimens in a blinded
fashion, interpretable THM-GC-EI/MS results were obtained for
391/395 (99%) of samples. However, the initial performance of
the assay demonstrated reduced sensitivity of 61.3% and reduced
specificity of 70.6%. Examination of unblinded results from the
395 samples made it possible to enhance the classification criteria
for interpreting the THM-GC-EI/MS chromatograms. When
mycocerosates are present well above the matrix then a strong pair
of doublets signal is generated and the above decision process is
straight forward, similarly for negative samples which have a clean
chromatogram. However, for samples where results are not
visually obvious a more rigorous method of assignment was
developed. Training of a new operator using the refined algorithm
resulted in an improved sensitivity and specificity of 64.9 and
76.3% respectively. Although a proportion (20.9%) of smear
negative culture positive cases were identified the detection rate for
smear positive cases of less than 75% is considered suboptimal for
the diagnosis of tuberculosis. It should be noted that the smear
positivity rate of 82.7% of culture confirmed cases observed in this
study is usually high for a sub Saharan African setting where co-
infection with HIV is common. In Zimbabwe during 2009, the
estimated smear positivity rate in new pulmonary cases was 29%
[1]. Following unblinding of the microbiological results, further
analysis suggested that the performance of the THM-GC-EI/MS
assay was being compromised due to the high background signal
in some samples. This was highly variable between samples and
may have been due to compounds of bacterial or human origin.
High levels of matrix compounds affect the performance of the
GC-MS instrument and its ability to separate compounds at trace
levels, also causing column overloading and blockages. In addition
to overloading the analytical capacity for individual samples, the
buildup of contamination within the injector, column and MS may
occur, necessitating periodic cleaning if large numbers of samples
are to be processed. To improve sensitivity, further optimization of
the sample preparation would be required to produce a cleaner
sample. Despite this, we have shown that THM-GC-EI/MS can
detect mycocerosic acids present in clinical sputum samples. The
time of the analysis was approximately two hours per sample and
sample handling was minimized by the use of online hydrolysis
and methylation. An attempt to use thermochemolysis for the
detection of M. tuberculosis directly in sputum, has been described
previously where the target was tuberculostearic acid (TBSA) [17].
Mycocerosic acids are a more suitable diagnostic biomarker for M.
tuberculosis than TBSA. Firstly, TBSA is less specific and present in
the bacteria belonging to the Actinomycetales which include
Nocardia and most mycobacteria. Secondly, TBSA is found in
several components in the cell membrane, which requires
complicated chemical extraction methods to release it, whereas
PDIM waxes have the advantage of being selectively extracted
from decontaminated sputum samples. Thirdly, TBSA is difficult
to identify because its branched C19 structure makes it hard to
separate it from stearic acid (C18) and similar acids; techniques,
such as column switching multi-dimensional GC, may be
necessary [5]. The mycocerosic acid methyl esters separate in an
Table 2. Secondary analysis of the performance of THM-GC-EI/MS compared to smear microscopy and culture on Lowenstein
Jensen.
Culture positive Smear
positive
Culture positive
Smear negative Culture negative Total samples
THM-GC-EI/MS positive 152 9 34 195
THM-GC-EI/MS negative 53 34 109 196
Indeterminate
# 11 2 4
Total samples 206 44 145 395
A refined algorithm for interpreting the THM-GC-EI/MS chromatograms, developed by using knowledge from an initial analysis of 395 samples, was applied in a second
round of blinded analysis by a newly trained operator.
#Four samples were not determined due to overloading of the GC column and were excluded from further analysis.
doi:10.1371/journal.pone.0032836.t002
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present and are more easily observed because the C29,C 30 and
C32 components appear as two characteristic doublet peaks. An
alternative GC-MS method for detecting mycocerosic acids uses
negative-ion chemical ionization (NICI) of pentafluorobenzyl
esters in sputum [10]. This method requires separate hydrolysis
and derivatisation which is slow and laborious. Similarly, another
complicated process, involving PDIMs isolation and hydrolysis,
permitted detection of sputum mycocerosates by electron capture
GC [5].
In order for an assay to be deployable in a routine diagnostic
laboratory, the extraction required must be simple, and the
analysis rapid and robust. Direct analysis of the sputum may be
performed using THM-GC-EI/MS (data not shown) but the
heterogeneity of the sample and high levels of background
contamination discourages this approach. The application of
liquid/liquid extraction of apolar lipids is attractive due to its
simplicity and potential for automation but our data suggest that
further clean up is necessary. Solid phase extraction (SPE) of the
PDIMs may improve sample quality and reduce the burden on the
analytical instrument from the matrix compounds. When
compared to culture THM-GC-MS methods offer rapid testing
with the potential to provide ‘same day’ analysis. They also reduce
the necessity to handle infectious materials. Amplification of
nucleic acids offers an alternative rapid test system. The recently
launched Xpert MTB/RIF assay (Cepheid, Sunnyvale, USA)
allows sensitive detection of M. tuberculosis DNA in less than two
hours [18,19]. However, the anticipated running costs are
substantial: approximately USD 21 per test in the public sector
of TB endemic countries [20] and considerably higher in the
private sector or industrialized countries. Should it prove
sufficiently sensitive and robust, through sample extraction
optimization, then THM-GC-EI/MS may provide a cost effective
alternative. However, the high cost of the instrumentation and use
of organic solvents may limit application in developing country
laboratories.
Materials and Methods
Ethical approval
The study and collection of samples at the Beatrice Road
Infectious Diseases Hospital was reviewed and approved by the
National Ethics Committee of the Medical Research Council of
Zimbabwe, Harare, Zimbabwe, the Institutional Review Board of
Biomedical Research and Training Center, Harare, Zimbabwe,
and the Research Ethics Committee of the London School of
Hygiene and Tropical Medicine, London, UK. Informed written
consent was obtained from all patients who enrolled in the study.
PDIM standards
The PDIM waxes were extracted and purified from M.
tuberculosis strain C [11] according to the procedures described
by Dobson et al. [12]. In essence, non-polar lipids were extracted
from freeze-dried biomass using a biphasic mixture of petroleum
ether and aqueous methanol. The main component of the PDIMs,
based on phthiocerol A [8], was purified from the petroleum ether
extract by preparative thin-layer chromatography [7].
M. tuberculosis culture
M. tuberculosis H37Rv (laboratory strain) was cultured in 10 mL
Middlebrook 7H9 broth, containing 0.2% Tween 80 (BDH
Becton Dickinson Diagnostic Systems, Sparks, MD) and 10%
albumin dextrose catalase enrichment (Becton Dickinson Diag-
nostic Systems, Sparks, MD) at 37uC for 10 days. Following this,
cells were harvested and re-suspended in sterile distilled water. A
Miles and Misra plate count was performed [21] and the colony
forming units (CFU) were estimated.
Clinical Samples
Sputum samples were collected from TB patients and suspects
presenting at Beatrice Road Infectious Diseases Hospital in
Harare, Zimbabwe as described by Mutetwa et al. [22]. Sputum
specimens were homogenized by vortexing with 4 mm beads, and
then split into two; one sample was used for smear microscopy and
culture. Fluorescent smear microscopy (auramine O) was under-
taken with positive samples confirmed by Ziehl-Neelsen (ZN)
staining. Positive cultures on Lowenstein Jensen were confirmed as
M. tuberculosis complex by MPB64 antigen detection (Capillia
TM,
Becton Dickinson, Sparks, MD, USA). The second aliquot of
sputum was stored frozen prior to shipment to London where they
were stored at 280uC prior to analysis by THM-GC-EI/MS. The
allocation of aliquots to either process was randomized to control
operator bias. Clinical and microbiological data were not revealed
to those undertaking the PDIMs analysis.
Sputum samples were processed in two batches; the first panel
(the test batch) consisted of 40 samples (20 smear positive culture
positive and 20 smear and culture negative), and the second panel
(the evaluation batch) consisted of 395 samples. Samples were
processed using a standard protocol routinely applied to sputum
prior to culture [14]. In brief, 0.5 mL of 4% sodium hydroxide
was added to 0.5 mL of each sample. Following mixing, samples
were left to stand for 20 min at room temperature with periodic
vortexing, after which an equal volume of neutralization buffer
was added (140 g/L potassium phosphate monobasic and 8 mL
1% phenol red). The mixtures were centrifuged at 3000 g for
30 min. The supernatants were decanted and the pellets re-
suspended in 10 mL sterile distilled water. Centrifugation was
repeated and the supernatants decanted leaving behind deposits
(approximately 1 mL). The deposits were heated in a water bath at
100uC for 30 min, in order to sterilize the samples. Deposits were
further concentrated by centrifugation at 14,000 g for 15 min,
leaving 0.2 mL deposits for subsequent apolar lipid extraction.
Apolar Lipid Extraction
The apolar lipids from dilutions of M. tuberculosis culture and
sputum specimens were extracted using a modified method from
Dobson et al. [12]. To 0.2 mL of deposit, 1.8 mL methanol and
1 mL petroleum ether 60–80uC (PE) were added and mixed on a
tube rotator for 15 min. After centrifugation at 1,200 g for 1 min,
the upper PE layer, containing the apolar lipids, was removed and
stored at 4uC.
Prior to analyzing the sputum samples, the performance of the
thermochemolysis and the extraction of PDIMs were evaluated
using samples spiked with PDIMs or bacteria harvested from
culture. Aliquots of negative pooled sputum (0.2 mL) were spiked
with a PDIMs standard (140–27,500 pg of total PDIMs). Each
spiked sample was vortexed for 30 seconds and then the apolar
lipids were extracted, following the procedure described above.
Assuming an extraction efficiency of 100%, then this would be
equivalent to a concentration range of PDIMs between 140–
27,500 pg/mL of petroleum ether. Hence the total quantity of
PDIMs analysed ranged between 7–1,375 pg/liner. M. tuberculosis
culture (140–5,600 CFU/mL) was spiked into 1 mL aliquots of
negative pooled sputum. Each sample was vortexed and
centrifuged at 14,000 g for 15 min. The supernatant was
discarded, leaving behind 0.2 mL deposit for apolar lipid
extraction.
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The equipment used was an Agilent 7890A GC coupled to a
5975C quadrupole MS, with an electron impact (EI) ionization
source set at 70 eV impact energy and 35 mA emission current. A
PAL-CTC autosampler, modified with a LINEX liner exchanger,
was used in conjunction with an Optic3 programmable temper-
ature vaporization (PTV) inlet. Testing of sputum extracts was
performed blinded with THM-GC-EI/MS operators not aware of
the microbiological and clinical data.
Fifty microlitres of the PE extract or of the PDIM solutions were
manually applied to a quartz wool plug inside the Optic glass liner
and dried at 60–70uC for 10 min. The liners were then loaded into
the autosampler. Following automated injection of 50 mL
methanolic tetramethylammonium hydroxide (TMAH) (12.5%),
derivatization of lipids was performed in the Optic3 PTV inlet at
380uC. The GC analysis was carried out on a DB-5MS capillary
column (15 m60.25 mm60.25 mm) (Agilent Technologies, UK)
with a temperature program of 50uC (8 min) to 350uC (1 min) @
30uC/min, and a carrier gas flow rate of 1.4 mL of helium per
min.
The mass spectrometer was operated in selected ion monitoring
(SIM) mode. The target compounds were detected by monitoring
for the largest fragment ions at m/z 88 and 101, which are
characteristic for all derivatised mycocerosates [10], and the
molecular ions m/z 452 (C29), 466 (C30) and 494 (C32) (Figure 1).
Quantification of the mycocerosic acid methyl esters was
performed by measuring the areas of the target peaks in the
chromatogram for the m/z 101 fragment ion. The quantitative
analyses are with respect to the total amount of PDIMs present
which includes the abundance of the C29/C30 and C32 peaks.
Throughout this paper, all the data analysis and interpretation
were done based on visual examination, and by using the
integration facility in Agilent ChemStation. As part of the data
interpretation, the sample chromatograms were aligned with the
daily run of PDIMs standard, the retention times (RT) were
examined for chromatographic drifting, and were corrected if
necessary.
Acknowledgments
We thank the participants and the staff of Beatrice Road Infectious Disease
Hospital for their cooperation with the study.
Author Contributions
Conceived and designed the experiments: R. McNerney ELC GHM
DEM. Performed the experiments: DO SCN SM. Analyzed the data: SCN
GHM R. McNerney R. Mutetwa MWB. Contributed reagents/materials/
analysis tools: OL SM DEM R. Mutetwa. Wrote the paper: R. McNerney
DO SCN DEM GHM.
References
1. World Health Organisation (2010) Global tuberculosis control:WHO Report
2010. Geneva.
2. McNerney R, Daley P (2011) Towards a point-of-care test for active
tuberculosis: obstacles and opportunities. Nat Rev Microbiol 9: 204–213.
3. Balabanova Y, Drobniewski F, Nikolayevskyy V, Kruuner A, Malomanova N,
et al. (2009) An integrated approach to rapid diagnosis of tuberculosis and
multidrug resistance using liquid culture and molecular methods in Russia. PLoS
One 4: e7129.
4. Redman JE, Shaw MJ, Mallet AI, Santos AL, Roberts CA, et al. (2009)
Mycocerosic acid biomarkers for the diagnosis of tuberculosis in the Coimbra
Skeletal Collection. Tuberculosis (Edinb) 89: 267–277.
5. Minnikin DE, Bolton RC, Hartmann S, Besra GS, Jenkins PA, et al. (1993) An
integrated procedure for the direct detection of characteristic lipids in
tuberculosis patients. Ann Soc Belg Me ´d Trop 73 Suppl 1: 13–24.
6. Daffe ´M ,L a n e ´elle MA (1988) Distribution of phthiocerol diester, phenolic
mycosides and related compounds in mycobacteria. J Gen Microbiol 134:
2049–2055.
7. Minnikin DE, Dobson G, Goodfellow M, Magnusson M, Ridell M (1985)
Distribution of some mycobacterial waxes based on the phthiocerol family. J Gen
Microbiol 131: 1375–1381.
8. Minnikin DE, Kremer L, Dover LG, Besra GS (2002) The methyl-branched
fortifications of Mycobacterium tuberculosis. Chem Biol 9: 545–553.
9. Minnikin DE, Besra GS, Bolton RC, Datta AK, Mallet AI, et al. (1993)
Identification of the leprosy bacillus and related mycobacteria by analysis of
mycocerosate profiles. Ann Soc Belg Me ´d Trop 73 Suppl 1: 25–34.
10. Alugupalli S, Sikka MK, Larsson L, White DC (1998) Gas chromatography
mass spectrometry methods for the analysis of mycocerosic acids present in
Mycobacterium tuberculosis. J Microbiol Methods 31: 143–150.
11. Mallet AI, Minnikin DE, Dobson G (1984) Gas-Chromatography Mass-
Spectrometry of tert-Butyldimethylsilyl Ethers of Phthiocerols and Mycocerosic
Alcohols from Mycobacterium tuberculosis. Biomed Mass Spectrom 11: 79–86.
12. Dobson G, Minnikin DE, Minnikin SM, Parlett JH, Goodfellow M, et al. (1985)
Systematic analysis of complex mycobacterial lipids. In: Goodfellow M,
Minnikin D, eds. Chemical Methods in Bacterial Systematics. London:
Academic Press. pp 237–265.
13. Dworzanski JP, Berwald L, Meuzelaar HLC (1990) Pyrolytic Methylation Gas-
Chromatography of Whole Bacterial-Cells for Rapid Profiling of Cellular Fatty-
Acids. Appl Environ Microbiol 56: 1717–1724.
14. Petroff SA (1915) A New and Rapid Method for the Isolation and Cultivation of
Tubercle Bacilli Directly from the Sputum and Feces. J Exp Med 21: 38–42.
15. Hobby GL, Holman AP, Iseman MD, Jones JM (1973) Enumeration of tubercle
bacilli in sputum of patients with pulmonary tuberculosis. Antimicrob Agents
Chemother 4: 94–104.
16. Yeager H, Jr., Lacy J, Smith LR, LeMaistre CA (1967) Quantitative studies of
mycobacterial populations in sputum and saliva. Am Rev Respir Dis 95:
998–1004.
17. Kaal E, Kolk AH, Kuijper S, Janssen HG (2009) A fast method for the
identification of Mycobacterium tuberculosis in sputum and cultures based on
thermally assisted hydrolysis and methylation followed by gas chromatography-
mass spectrometry. J Chromatogr A 1216: 6319–6325.
18. Helb D, Jones M, Story E, Boehme C, Wallace E, et al. (2010) Rapid detection
of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-
patient technology. J Clin Microbiol 48: 229–237.
19. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, et al. (2011)
Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the
Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a
multicentre implementation study. Lancet 377: 1495–1505.
20. World Health Organisation (2011) Rapid implementation of the Xpert MTB/
RIF diagnostic test. Geneva: WHO.
21. Miles AA, Misra SS, Irwin JO (1938) The estimation of the bactericidal power of
the blood. J Hyg (Lond) 38: 732–749.
22. Mutetwa R, Boehme C, Dimairo M, Bandason T, Munyati SS, et al. (2009)
Diagnostic accuracy of commercial urinary lipoarabinomannan detection in
African tuberculosis suspects and patients. Int J Tuberc Lung Dis 13:
1253–1259.
Mycocerosates from M. tuberculosis in Sputum
PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e32836